Introduction: One-stage oral disinfection technique has been developed to prevent cross-contamination between the treated and untreated areas between treatment sessions. Considering the role of inflammatory mediators in periodontitis, this study has been designed to compare the effects of one-stage oral disinfection with quadrant scaling and root planing (Q-SRP) on serum interleukin-27 (IL-27) levels in patients with moderateto-advanced periodontitis.
INTRODUCTION
Periodontal diseases are among the most common oral and dental diseases. 1 Periodontitis is a chronic inflamma tory disease in which an inflammatory process destroys the dental supporting structures and bone lysis, and creates periodontal envelopes. 2 Aggregatibacter actinomycetemcomitans, Tannerella forsythia, and Porphyromonas gingivalis are known as primary microbial agents, but
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several other microorganisms are associated with perio dontal diseases. 36 Most of these bacterial species are not only the microbial flora of the subgingival plaque, but are also colonized on mucosal surfaces, the tongue, and tonsil; they are commonly found in saliva. 711 Since the indi vidual's susceptibility to develop such diseases cannot be changed at the clinical level (except for antiinflammatory drugs), periodontal treatment will focus on reducing or eliminating periodontal pathogens, eliminating the possibility of their recolonization (mainly through the removal of envelopes), and creation of an inappropriate environment (with less anaerobic conditions) for bacte rial pathogens. It should be noted that modern therapies are based on nonspecific plaque hypothesis, which also eliminates the useful bacterial species. 810 Several studies have shown that the presence of periodontal pathogens (restoration or colonization after treatment) is associated with the adverse outcomes of periodontal treatment. 1116 The usual nonsurgical method for treatment of periodontitis is QSRP through multiple sessions. After mechanical removal, the microbial volume of the subgingival plaque decreases to 0.1% before treat ment. 8 However, after a week, the periodontal envelopes are occupied by the same amount of bacteria, but with less pathogenicity. 17, 18 The proliferation of bacteria in the subgingival region, 19 junctional epithelium, and envelope epithelium, 20 or bacteria in the dentinal tubules, posterior surface of the tongue, and tonsils are considered as poten tial sources of this gingival colonization. 21 Observations
show that plaque along with bacteria in the tongue, oral mucosa, tonsils, and saliva affect the colonization of bac teria in the gingival area after treatment. 21 Based on the above perspective, Quirynen et al 22 suggested a onestage FMD method, which aims to eliminate or at least suppress all periodontal pathogens from the oropharyngeal area (periodontal envelope, saliva, oral mucosa, and tonsils) within 24 hours using SRP of the entire mouth. In this method, until the peri odontal envelope is restored, recolonization of bacteria is delayed through crosscontamination. The above method is a relatively new method and there is a lot of discussion about the effectiveness, rationality, comfort of the patient and the dentist, systemic effects, as well as its costeffectiveness. Therefore, numerous clinical and paraclinical studies have been conducted with dissimilar results that have made it difficult to judge the method in this field. Some studies did not find any difference between this method and the conventional method of QSRP, 2226 whereas others emphasized the benefits of the new method. 27, 28 The clinical parameters, including BOP, CAL (clinical adhesion loss), and PD indicate the disease activity, degree of degradation, and progression of the disease. 29 Several studies, using these parameters, compared FMD method with QSRP. One study clearly showed the benefits of FMD as (1) attachment gain; (2) decreased depth of the envelope; and (3) decreased micro biological tendency. 29, 30 Apatzidou and Kinane 31 also reported the benefits of FMD (0.88 mm attachment) in deep envelopes. Most studies have addressed the clinical and microbiological parameters of this method; only one study reported the immunological effects of this method by suggesting a significant reduction in preinflammatory and inflamma tory mediators. 31, 32 Another new and effective method for the diagnosis and determination of periodontal disease activity is the measurement of serum biomark ers. Interleukin27 is an antiinflammatory cytokine that inhibits IL17. 33 In this study, in addition to clinical parameters, the inflammatory process between the FMD method and QSRP was investigated by the measurement of serum IL27. Furthermore, IL27 changes were also examined before and after applying two different thera peutic strategies to investigate the periodontal therapeutic effects on the serum levels of inflammatory cytokines, the efficacy of the two abovementioned treatments in increasing these cytokines, and the disease progression.
MATERIALS AND METHODS
Twenty patients were randomly assigned to two groups using toss of a coin, after meeting the inclusion and exclu sion criteria (the first group was treated by FMD, and the second group was treated using standard method, namely QSRP). Blood samples were taken once before treatment, and then at 2 and 4month intervals after treatment. They were sent to the laboratory for evaluation of biomarkers (IL27) with specific kits.
Inclusion Criteria
• Patients with moderate-to-advanced periodontitis.
• Patients aged 25 to 70 years with at least 12 teeth (without considering the third molars and teeth with orthodontic bridges, crowns, and implants) and diagnosis of advanced chronic periodontitis with 30% presence of teeth with loss of clinical attachment of 3 mm or more and the presence of radiographic signs of bone resorption.
Exclusion Criteria
• Systemic diseases (such as diabetes mellitus, cancer, acquired immunodeficiency syndrome, and bone metabolic diseases) • Diseases that delay wound healing; history of radio therapy or treatment with immune system suppressor, autoimmune diseases, allergy, and other infectious diseases Patients in the control group underwent SRP treat ments at 2week intervals for each quadrant after the blood samples were taken. In the test group, after sampling, the whole mouth was cleaned by an ultrasonic scaling apparatus in two sessions with a time interval of less than 24 hours to reduce the count of pathogenic organisms.
Subgingival rinsing of all envelopes was carried out with 0.2% chlorhexidine using an insulin syringe to remove all the remaining bacteria. An antiseptic agent (0.2% chlorhexidine) was used to brush the tongue's posterior surface to decrease the bacterial load in the area and an antiseptic mouthwash (0.2% chlorhexidine) was used to reduce bacteria in the saliva and on the tonsils.
The variables studied included serum IL27 levels, as well as the clinical parameters, such as BOP, CAL, and PD, which were measured before starting treatment and then again at 2 and 4month intervals after treatment. The plaque index was measured by the O'Leary method with the aim of maintaining this index at a value below 10% (by educating on the plaque control methods) in the 2nd, 4th, 8th, 12th, and 16th week intervals after treatment.
The plaque and gingival indexes were considered as control variables and patients with inappropriate coop eration (high plaque index in periodic examinations) were excluded from the study process.
Measurement of the Clinical Parameters
• Bleeding on probing: Each tooth was probed at four levels of mesial, distal, buccal, and lingual; the probe was slowly drawn and removed with gentle force from the depth of the envelope. We waited for 30 to 60 seconds before examining the bleeding in each area. Finally, the data obtained from the study were analyzed by descriptive statistics [mean ± standard deviation (SD)] and parametric statistical methods including the mean of dependent groups by paired samples ttest and analyzed by SPSS 16 software. The normal distribution of data was assessed by Kolmogorov-Smirnov test and analysis of variance (ANOVA) test was used to compare any probable difference between the tested groups. In this study, pvalue less than 0.05 was considered statistically significant.
RESULTS
In the FMD group, 45% were male and 55% were female. In the QSRP group, 60% were male and 40% were female. Chisquare test did not show any significant difference in the gender frequency between the two groups. The mean age in the FMD group was 43 years and in QSRP group was 47.7 years and there was no significant difference in the mean age of the patients (p = 0.26).
The distribution of data was evaluated at three dif ferent times (before treatment, then at 2 and 4month intervals after treatment) by Kolmogorov-Smirnov test. The results showed that all the data in the study had a normal distribution (p > 0.05).
According to Table 1 and Graph 1, in the FMD group, the mean serum IL-27 was 50.5 before treatment, which increased to 59.3 after 2 months of treatment and reached 59.6 after the 4-month interval of treatment. The ANOVA (within group) indicated no significant difference in serum IL27 levels at the studied intervals (before treat ment, 2 and 4month intervals after treatment). In the QSRP group, the mean serum IL27 before treatment was 46.6, which increased to 55.7 in 2 months after treatment and reached 57.4 in 4 months after treatment. The ANOVA (within group) of QSRP group showed a significant difference in serum IL27 levels among inter vals (before treatment, 2, and 4 months after treatment) (p < 0.05). The Scheffe post hoc test was used to evaluate and compare the intervals pairwise in the QSRP group. The procedure showed that serum IL27 levels differed significantly before treatment and 2 months later with a mean difference of 9.1 (p < 0.05). The mean serum IL-27 had a significant difference of 10.8% before the treatment and 4 months after treatment (p < 0.05) as well. There was no significant difference (1.7%) in the serum IL17 levels between the 2 and 4month intervals after treatment.
According to Table 2 and Graph 2, in the FMD group, the mean PD before treatment was 4.1; 2 months after treatment, it was 2.7, and 4 months after treatment, it was 2.6, which showed a significant difference in PD among the studied intervals, according to ANOVA test (within group) (p < 0.01). The Scheffe post hoc test showed that PD had a significant difference before the treatment and 2 months after the treatment (p < 0.05) with mean differ ence of 1.42 mm. Also, the mean PD had a significant dif ference before the treatment and 4 months after treatment with a mean difference of 1.5 mm (p < 0.05). However, there was no significant difference in PD levels between the 2 and 4month intervals after treatment with only a 0.15 mm difference in mean values. In the Q-SRP group, the mean PD before treatment was 4.18; 2 months after treatment, it was 2.7, and 4 months after treatment, it was 2.57, which according to ANOVA (within group) is a significant difference in PD among the tested intervals (p < 0.01). Based on the Scheffe post hoc test, PD had a sig nificant difference before treatment and 2 months later with a mean difference of 1.43 mm (p < 0.05). Also, the mean PD had a significant difference before treatment and 4 months after treatment with mean difference of 1.61 mm (p < 0.05). The PD levels did not differ significantly between 2 and 4 months after treatment with 0.17 mm difference (p > 0.05).
According to Table 3 and Graph 3, in the FMD group, the mean CAL before treatment was 4.2 mm; 2 months after treatment, it was 3.4 mm, and 4 months after treat ment, it was 2.78 mm. According to the ANOVA test (within group), there was a significant difference in mean CAL at the tested intervals (p < 0.01). In the QSRP group, the mean CAL before treatment was 4.2 mm; 2 months after treatment, it was 3.02 mm, and 4 months after treat ment, it was 2.57, which according to the ANOVA test (within group) is a significant difference in CAL among the studied intervals (p < 0.01).
According to Table 4 and Graph 4, in the FMD group, the mean BOP before treatment was 73.8%; 2 months after treatment, it was 17.9%, and 4 months after treatment, it was 2.7%. According to ANOVA test (within group), there was a significant difference in BOP among the studied intervals (p < 0.01). In the QSRP group, the mean BOP before treatment was 72.75%; 2 months after treatment, it was 15.7%, and 4 months after treatment, it was 6.6%, which according to ANOVA test (within group) is a significant difference in BOP among the studied intervals (p < 0.01).
The Scheffe post hoc test in both groups, while exam ining CAL and BOP indices, shows that (Tables 3, 4 and Graphs 3, 4):
• CAL and BOP before treatment and 2 months later had a significant difference in each group (p < 0.05).
• The mean CAL and BOP before treatment and 4 months after treatment were significantly different in each group (p < 0.05). Table 5 and in accordance with t-test, PD and CAL levels before treatment, and after the 2 and 4month intervals of treatment did not show significant difference between FMD and Q-SRP groups (p > 0.05). According to the same table, serum levels of IL27 before treatment and BOP in the 2 and 4month intervals after treatment showed a significant difference between FMD and Q-SRP groups (p < 0.05).
DISCUSSION
Both FMD and QSRP are effective methods for the treat ment of periodontal diseases, and many studies confirm this claim. 28, 3438 The purpose of FMD is to remove or at least suppress all periodontal pathogens rapidly from the oropharyngeal area. 39, 40 In this method, bacterial coloni zation is postponed until better restoration of the peri odontal envelope. The above method is a relatively new method and there is a lot of discussion about the effec tiveness, rationale, comfort level of patient and dentist, systemic effects, as well as its costeffectiveness. 39, 40 Therefore, many clinical and paraclinical studies have been conducted with varying results, making it difficult to pronounce a clear judgment. 39, 40 A new and effective method for diagnosis of periodontal disease and deter mination of its activity is by the measurement of serum biomarkers. In this regard, at this center, serum levels of interleukins 17 and β1 were evaluated during the course of scaling treatments and the results indicate a reduction in serum levels of these two proinflammatory interleukins. 34 Further, to complete these activities and continue the pre vious research, we investigated the level of IL27 changes as an antiinflammatory interleukin during treatment. Interleukin27 is a relatively new cytokine that belongs to the IL12 family. Interleukin27 is a cytokine derived from antigenpresenting cells, which, in recent years, is a major cytokine in acquired immune responses, and plays its role through the regulation of Tcelldependent immune responses. The receptor of this cytokine is found in natural killer T cells, B, T, and mast cell, macrophage, dendritic cell, and endothelial cells. 40, 41 According to some studies, IL27 has a proinflammatory role in some diseases, such as autoimmune diseases, while some studies have defined an antiinflammatory role for this IL. The existing theory suggests that IL27 prevents the production of IL1, IL6, and IL17 preinflammatory cytokines, and induces production of antiinflammatory cytokine IL10. 40, 41 Most studies on IL27 have evaluated the clinical and microbiological aspects of this cytokine. However, in this study, in addition to clinical parameters, the immunologi cal effects have been investigated too, suggesting that an increase in IL27 acts as an antiinflammatory interleukin.
In the study of Apatzidou et al, 23 the effects of FMD and quadrant method were evaluated on antibody titers. The results of this study showed that both treatments reduced the antibody titer during the study period (6 months). In this study, the effect of FMD and QSRP on serum levels of IL27 was compared in patients with moderate toadvanced periodontitis. The results showed that the mean serum IL27 increased in the 4th month in both methods without a significant difference in mean serum levels of IL27 between the 2 and 4month intervals after treatment in any of the groups. In the FMD group, there was no significant difference between the mean serum IL27 levels of the study intervals. In the QSRP group, there was a significant difference between the 2 or 4 month intervals after treatment and before the treatment values. Following the cause of this phenomena, it can be stated that according to previous studies, due to the stimulatory effect of the first session of scaling on produc tion of an immune response (vaccinelike effect), the level of IL27 increased during these two followup periods.
On examining the periodontal indices (BOP, CAL, and PD), clinical improvements were observed in both groups, but there was no significant difference in improvement of CAL and PD periodontal indices between the two groups. In a systematic study, published in 2008, a very small dif ference was observed in the clinical parameters, evaluated between the two methods in the treatment of chronic adult periodontitis. 38 Predin et al 42 The effect of FMD has been studied in several pro spective studies. [45] [46] [47] [48] All of these studies are conducted in accordance with the main standard. In the control group, recolonization of the treated envelopes occurred long before the debridement time of all quadrants (during 4648 All the studies reported better clinical outcomes in the experimental group, including a significant reduc tion in BOP, CAL, and PD. 4648 These clinical results were confirmed by the improvement of clinical indicators in these studies. The disinfection technique in FMD dramatically reduces the incidence of periodontal abnormal pathogens, especially in the subgingival area and to a lesser extent in the internal oral nests. Several possible explanations were considered for the reported success of FMD. All of the above studies stated that when the possibility of trans fer and transduction of intraoral periodontal pathogens decreases, the nonsurgical periodontal treatment will improve. The mechanism of intraoral transfer of these pathogens is still not well defined. However, it seems that the saliva, in which all bacterial species are able to survive, plays an important role in this regard. Changing the direct position of the periodontal pathogens through the flow of saliva into periodontal envelopes appears to be unlikely due to the outflow of the subgingival fluid. The indirect impact of any change in the upper gingival plaque that may gradually expand to the subgingival area is a more rational explanation for this phenomenon. In fact, several studies have suggested that at least a portion of the gingi val microbiota depends on the presence of upper gingival plaque. [49] [50] [51] [52] [53] However, it should be noted that bacteria can also be displaced by contaminated health supplies and infected dentistry devices that enter the envelope. 54 Many studies have reported that toothbrushes used daily could be a reservoir for complex periodontal microbiota.
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CONCLUSION
• According to the findings of this study, both FMD and QSRP procedures have been successful in improving clinical periodontal indices.
• Both methods increased serum levels of the inflam matory mediator IL27 during the study period along with the improvement of periodontal clinical indicators.
